Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1991 1
1994 2
1995 3
1996 3
1997 1
1998 2
1999 6
2000 1
2001 5
2002 3
2003 1
2004 3
2005 2
2006 2
2007 1
2008 2
2009 3
2010 2
2011 1
2012 3
2013 1
2014 1
2015 4
2016 3
2017 3
2018 3
2020 3
2021 3
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study.
Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL; CONVERT Study Group. Griffith DE, et al. Among authors: field sk. Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC. Am J Respir Crit Care Med. 2018. PMID: 30216086 Clinical Trial.
Embrace simplicity when treating lady windermere.
Jarand J, Field SK. Jarand J, et al. Among authors: field sk. Chest. 2014 Aug;146(2):244-246. doi: 10.1378/chest.14-0046. Chest. 2014. PMID: 25091749 No abstract available.
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
Griffith DE, Thomson R, Flume PA, Aksamit TR, Field SK, Addrizzo-Harris DJ, Morimoto K, Hoefsloot W, Mange KC, Yuen DW, Ciesielska M, Wallace RJ Jr, van Ingen J, Brown-Elliott BA, Coulter C, Winthrop KL; CONVERT Study Group. Griffith DE, et al. Among authors: field sk. Chest. 2021 Sep;160(3):831-842. doi: 10.1016/j.chest.2021.03.070. Epub 2021 Apr 19. Chest. 2021. PMID: 33887244 Free article. Clinical Trial.
New treatment options for multidrug-resistant tuberculosis.
Field SK, Fisher D, Jarand JM, Cowie RL. Field SK, et al. Ther Adv Respir Dis. 2012 Oct;6(5):255-68. doi: 10.1177/1753465812452193. Epub 2012 Jul 4. Ther Adv Respir Dis. 2012. PMID: 22763676 Free article. Review.
Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
Alhabeeb FF, Whitmore GA, Vandemheen KL, FitzGerald JM, Bergeron C, Lemière C, Boulet LP, Field SK, Penz E, McIvor RA, Gupta S, Mayers I, Bhutani M, Hernandez P, Lougheed D, Licskai CJ, Azher T, Cote A, Ainslie M, Fraser I, Mahdavian M, Aaron SD. Alhabeeb FF, et al. Among authors: field sk. Respir Med. 2022 Aug-Sep;200:106917. doi: 10.1016/j.rmed.2022.106917. Epub 2022 Jul 3. Respir Med. 2022. PMID: 35850008
76 results